Tags

Allergan

News and updates about Allergan

Teva completes acquisition of Allergan generics arm

Teva Pharmaceutical completes $40 billion acquisition of the generics arm of rival Allergan.

Teva completes acquisition of Allergan generics arm

Teva's $40.5 Billion deal expected to go through next week

Israeli pharmaceutical company wins regulatory approval for acquisition of Allergan, conditional upon giving up some of its products.

Teva's $40.5 Billion deal expected to go through next week

Israeli Pharma Giant Teva Buys Botox's Allergan

$40.5 billion purchase solidifies Teva as world leader in generic drugs, after $40.1 billion bid for rival Mylan meets resistance.

Israeli Pharma Giant Teva Buys Botox's Allergan